Cost of Revenue

$390.60M

Quarterly · Period ending: Jun 30, 2026 · USD

EW Cost of Revenue

Latest reported$390.60Mperiod endingJun 30, 2026

EW Quarterly Cost of Revenue ($123.00M → $390.60M)

Quarterly cost of revenue

High-resolution chart · PNG

EW cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2026	390,600,000
Mar 31, 2026	359,300,000
Dec 31, 2025	340,600,000
Sep 30, 2025	345,200,000
Jun 30, 2025	342,600,000
Mar 31, 2025	301,600,000
Dec 31, 2024	292,200,000
Sep 30, 2024	262,900,000
Jun 30, 2024	297,800,000
Mar 31, 2024	289,300,000
Dec 31, 2023	251,000,000
Sep 30, 2023	272,200,000
Jun 30, 2023	270,800,000
Mar 31, 2023	359,300,000
Dec 31, 2022	295,600,000
Sep 30, 2022	280,900,000
Jun 30, 2022	285,700,000
Mar 31, 2022	306,600,000
Dec 31, 2021	311,100,000
Sep 30, 2021	300,900,000
Jun 30, 2021	326,000,000
Mar 31, 2021	287,900,000
Dec 31, 2020	295,000,000
Sep 30, 2020	286,900,000
Jun 30, 2020	245,900,000
Mar 31, 2020	271,200,000
Dec 31, 2019	295,400,000
Sep 30, 2019	305,200,000
Jun 30, 2019	315,300,000
Mar 31, 2019	239,400,000
Dec 31, 2018	236,200,000
Sep 30, 2018	220,300,000
Jun 30, 2018	233,500,000
Mar 31, 2018	232,100,000
Dec 31, 2017	235,100,000
Sep 30, 2017	216,400,000
Jun 30, 2017	208,900,000
Mar 31, 2017	218,100,000
Dec 31, 2016	210,300,000
Sep 30, 2016	198,100,000
Jun 30, 2016	202,500,000
Mar 31, 2016	180,300,000
Dec 31, 2015	175,900,000
Sep 30, 2015	146,700,000
Jun 30, 2015	158,600,000
Mar 31, 2015	136,000,000
Dec 31, 2014	160,400,000
Sep 30, 2014	168,100,000
Jun 30, 2014	151,200,000
Mar 31, 2014	145,900,000
Dec 31, 2013	145,500,000
Sep 30, 2013	129,700,000
Jun 30, 2013	125,000,000
Mar 31, 2013	122,200,000
Dec 31, 2012	125,800,000
Sep 30, 2012	111,700,000
Jun 30, 2012	129,800,000
Mar 31, 2012	127,300,000
Dec 31, 2011	119,600,000
Sep 30, 2011	125,600,000
Jun 30, 2011	127,800,000
Mar 31, 2011	116,800,000
Dec 31, 2010	113,500,000
Sep 30, 2010	95,800,000
Jun 30, 2010	100,400,000
Mar 31, 2010	98,600,000
Dec 31, 2009	101,700,000
Sep 30, 2009	98,500,000
Jun 30, 2009	101,900,000
Mar 31, 2009	97,000,000
Dec 31, 2008	98,800,000
Sep 30, 2008	104,900,000
Jun 30, 2008	113,000,000
Mar 31, 2008	102,900,000
Dec 31, 2007	99,600,000
Sep 30, 2007	90,700,000
Jun 30, 2007	94,700,000
Mar 31, 2007	93,200,000
Dec 31, 2006	97,400,000
Sep 30, 2006	87,400,000
Jun 30, 2006	95,700,000
Mar 31, 2006	93,000,000
Dec 31, 2005	89,600,000
Sep 30, 2005	90,900,000
Jun 30, 2005	97,900,000
Mar 31, 2005	96,200,000
Dec 31, 2004	91,200,000
Sep 30, 2004	87,900,000
Jun 30, 2004	92,400,000
Mar 31, 2004	98,700,000
Dec 31, 2003	93,800,000
Sep 30, 2003	86,900,000
Jun 30, 2003	89,600,000
Mar 31, 2003	89,100,000
Dec 31, 2002	85,700,000
Sep 30, 2002	69,900,000
Jun 30, 2002	74,400,000
Mar 31, 2002	69,100,000
Dec 31, 2001	68,200,000
Sep 30, 2001	64,400,000